Strata Critical Medical annual revenue
2019
2020
2021
2022
2023
2024
2025
Strata Critical Medical reported $197.1M in revenue for fiscal 2025, an increase of 34.28% from the previous fiscal year.
View full Strata Critical Medical company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $197.1M | $50.3M | +34.28% |
| 2024 | 2024-12-31 | $146.8M | −$78.4M | −34.80% |
| 2023 | 2023-12-31 | $225.2M | $79.1M | +54.11% |
| 2022 | 2022-12-31 | $146.1M | — | — |
| 2021 | 2021-09-30 | $50.5M | $27.1M | +115.61% |
| 2020 · Sep 30 | 2020-09-30 | $23.4M | −$7.8M | −24.88% |
| 2019 · Sep 30 | 2019-09-30 | $31.2M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $72.5M | $27.4M | +60.74% |
| Q1 2026 | 2026-03-31 | $67.4M | $31.4M | +87.45% |
| Q4 2025 | 2025-12-31 | $66.8M | $75.5M | +867.31% |
| Q3 2025 | 2025-09-30 | $49.3M | $13.2M | +36.70% |
| Q2 2025 | 2025-06-30 | $45.1M | −$22.8M | −33.61% |
| Q1 2025 | 2025-03-31 | $35.9M | −$15.6M | −30.22% |
| Q4 2024 | 2024-12-31 | −$8.7M | −$56.2M | −118.33% |
| Q3 2024 | 2024-09-30 | $36.1M | −$35.4M | −49.52% |
| Q2 2024 | 2024-06-30 | $67.9M | $7.0M | +11.41% |
| Q1 2024 | 2024-03-31 | $51.5M | $6.2M | +13.79% |
| Q4 2023 | 2023-12-31 | $47.5M | $9.3M | +24.50% |
| Q3 2023 | 2023-09-30 | $71.4M | $25.7M | +56.25% |
| Q2 2023 | 2023-06-30 | $61.0M | $25.4M | +71.16% |
| Q1 2023 | 2023-03-31 | $45.3M | $18.6M | +70.00% |
| Q4 2022 | 2022-12-31 | $38.1M | $13.5M | +54.91% |
| Q3 2022 · Sep 30 | 2022-09-30 | $45.7M | $25.4M | +125.05% |
| Q3 2022 · Jun 30 | 2022-06-30 | $35.6M | $22.7M | +175.14% |
| Q2 2022 | 2022-03-31 | $26.6M | $17.4M | +187.18% |
| Q1 2022 | 2021-12-31 | $24.6M | — | — |
| Q4 2021 | 2021-09-30 | $20.3M | — | — |
| Q2 2021 | 2021-06-30 | $13.0M | $9.5M | +276.70% |
| Q1 2021 | 2021-03-31 | $9.3M | — | — |
| Q2 2020 | 2020-06-30 | $3.4M | — | — |
Strata Critical Medical's latest reported quarter, Q2 2026, generated $72.5M in revenue, an increase of 60.74% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Strata Critical Medical source filings ↗